Skip to main content
. Author manuscript; available in PMC: 2015 May 6.
Published in final edited form as: Cancer Cell. 2009 Oct 6;16(4):295–308. doi: 10.1016/j.ccr.2009.08.021

Figure 5. Chronic hepatitis and HCC incidence in tg1223 mice, tg1223 mice intercrossed with various knockout mice and LTβR-Ig treated tg1223 mice.

Figure 5

(A) Chronic hepatitis and HCC incidence in 12 month-old tg1223 and C57BL/6 mice. (B) Chronic hepatitis and HCC incidence in 18 month-old tg1223 and intercrossed tg1223 mice. (C) Reduced chronic hepatitis and HCC incidence in 12 month-old tg1223 mice treated with LTβR-Ig. Statistical evaluation: *, **, *** indicate the degree of statistical significance: * = p<0.05; ** = p<0.001; *** = p<0.0001.